AstraZeneca said that its vaccine developed with the University of Oxford appeared to offer limited protection against mild disease caused by the South African variant of COVID-19.
- Inicio
- > AstraZeneca
- > Oxford COVID shot 'less effective on South Africa variant'
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook